PM20D1 and Alzheimer disease: For the ROSMAP cohort, methylation level of PM20D1 might be positively associated with amyloid in AD patients (p < 0.05 for 3 out of 8 probes in total), but not in MCI (1 probe), nor control (0 probe) or the overall group (1 probe) (Additional file 5: Table S5).